SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-17-007458
Filing Date
2017-12-27
Accepted
2017-12-27 16:30:27
Documents
3
Period of Report
2017-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 f12261708k.htm 8-K 44134
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 17551
3 humanigen_logo.jpg GRAPHIC 25558
  Complete submission text file 0001214659-17-007458.txt   98553
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 171276390
SIC: 2834 Pharmaceutical Preparations